Showing results (651-660 of 713) with videos related to
Sort By:
Pageof 72
Oncology Research and Treatment|November 25, 2015
Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib TherapyOliver Gautschi, Carola Stadelmann, Franziska Aebersold-Keller, et al.Science Translational Medicine|December 8, 2017
BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesionsMaryam K Fard, Franziska van der Meer, Paula Sánchez, et al.Nature|March 15, 2019
Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degenerationDmitri Lodygin, Moritz Hermann, Nils Schweingruber, et al.Neuroscience and Biobehavioral Reviews|February 26, 2018
The role of the cerebellum in multiple sclerosis-150 years after CharcotKatrin Parmar, Christine Stadelmann, Maria A Rocca, et al.Molecular Oncology|January 18, 2025
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survivalBarnabas Irmer, Darius Wlochowitz, Carolin Krekeler, et al.Nature Neuroscience|June 27, 2024
T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosisShreeya Kedia, Hao Ji, Ruoqing Feng, et al.Nature|February 22, 2019
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degenerationDmitri Lodygin, Moritz Hermann, Nils Schweingruber, et al.Biomaterials|January 20, 2020
Orbital floor repair using patient specific osteoinductive implant made by stereolithographyOlivier Guillaume, Mike A Geven, Viktor Varjas, et al.The New England Journal of Medicine|January 24, 2019
A Randomized Trial of Endometrial Scratching before In Vitro FertilizationSarah Lensen, Diana Osavlyuk, Sarah Armstrong, et al.Acta Neuropathologica|April 8, 2017
Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosisNielsen Lagumersindez-Denis, Claudia Wrzos, Matthias Mack, et al.Pageof 72